HUE029431T2 - Injectable supersaturated acetaminophen solution for spinal administration - Google Patents

Injectable supersaturated acetaminophen solution for spinal administration Download PDF

Info

Publication number
HUE029431T2
HUE029431T2 HUE13765450A HUE13765450A HUE029431T2 HU E029431 T2 HUE029431 T2 HU E029431T2 HU E13765450 A HUE13765450 A HU E13765450A HU E13765450 A HUE13765450 A HU E13765450A HU E029431 T2 HUE029431 T2 HU E029431T2
Authority
HU
Hungary
Prior art keywords
acetaminophen
solution
supersaturated
injectable
aqueous
Prior art date
Application number
HUE13765450A
Other languages
English (en)
Hungarian (hu)
Inventor
Augusto Mitidieri
Elisabetta Donati
Nicola Caronzolo
Original Assignee
Sintetica S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46690603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE029431(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sintetica S A filed Critical Sintetica S A
Publication of HUE029431T2 publication Critical patent/HUE029431T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HUE13765450A 2012-06-29 2013-06-27 Injectable supersaturated acetaminophen solution for spinal administration HUE029431T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001154A ITMI20121154A1 (it) 2012-06-29 2012-06-29 Soluzione iniettabile di acetaminofene per la somministrazione spinale

Publications (1)

Publication Number Publication Date
HUE029431T2 true HUE029431T2 (en) 2017-03-28

Family

ID=46690603

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13765450A HUE029431T2 (en) 2012-06-29 2013-06-27 Injectable supersaturated acetaminophen solution for spinal administration

Country Status (44)

Country Link
US (2) US11344517B2 (OSRAM)
EP (1) EP2874602B1 (OSRAM)
JP (1) JP5876620B2 (OSRAM)
KR (1) KR102118227B1 (OSRAM)
CN (1) CN104487051B (OSRAM)
AP (1) AP2014008152A0 (OSRAM)
AR (1) AR091633A1 (OSRAM)
AU (1) AU2013282753B2 (OSRAM)
BR (1) BR112014032818B1 (OSRAM)
CA (1) CA2876801C (OSRAM)
CL (1) CL2014003536A1 (OSRAM)
CO (1) CO7240357A2 (OSRAM)
CR (1) CR20150036A (OSRAM)
CU (1) CU20140150A7 (OSRAM)
CY (1) CY1117691T1 (OSRAM)
DK (1) DK2874602T3 (OSRAM)
DO (1) DOP2014000302A (OSRAM)
EA (1) EA028909B1 (OSRAM)
EC (1) ECSP15000500A (OSRAM)
ES (1) ES2578012T3 (OSRAM)
GE (1) GEP201706689B (OSRAM)
HR (1) HRP20160706T1 (OSRAM)
HU (1) HUE029431T2 (OSRAM)
IL (1) IL236423A (OSRAM)
IT (1) ITMI20121154A1 (OSRAM)
MA (1) MA37811B1 (OSRAM)
MD (1) MD4537C1 (OSRAM)
ME (1) ME02431B (OSRAM)
MX (1) MX369264B (OSRAM)
MY (1) MY169251A (OSRAM)
NI (1) NI201400147A (OSRAM)
NZ (1) NZ703829A (OSRAM)
PE (1) PE20150331A1 (OSRAM)
PH (1) PH12015500178B1 (OSRAM)
PL (1) PL2874602T3 (OSRAM)
PT (1) PT2874602T (OSRAM)
RS (1) RS54844B1 (OSRAM)
SG (2) SG11201408479WA (OSRAM)
SI (1) SI2874602T1 (OSRAM)
SM (1) SMT201600248B (OSRAM)
TN (1) TN2014000526A1 (OSRAM)
UA (1) UA117101C2 (OSRAM)
WO (1) WO2014002042A1 (OSRAM)
ZA (1) ZA201409478B (OSRAM)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0646400B1 (en) * 1993-04-14 2001-07-18 Nippon Sanso Corporation Dissolved oxygen reducing apparatus
US6171298B1 (en) * 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
FR2809619B1 (fr) 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
DE10112325A1 (de) * 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols
RS53804A (sr) * 2001-12-18 2006-12-15 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Parenteralna kompozicija paracetamola
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
DE102005037653A1 (de) * 2005-08-05 2007-02-15 Theraselect Gmbh Stabile, flüssige Formulierung von Paracetamol
JP4929352B2 (ja) * 2006-07-18 2012-05-09 スペイン ファルマ ソシエダ アノニマ 注入可能なパラセタモール液剤
CN101015542A (zh) * 2007-02-13 2007-08-15 天津生机集团有限公司 家畜用复方对乙酰氨基酚注射液及其制备方法
MD3528G2 (ro) * 2007-09-28 2008-11-30 Сергей ШАНДРУ Metodă de anestezie spinală continuă la pacienţii în etate
WO2009064928A1 (en) * 2007-11-13 2009-05-22 Cadence Pharmaceuticals Reduced dose intravenous acetaminophen
EP2307056B1 (en) 2008-01-17 2021-12-15 Pharmis Biofarmacêutica, LDA Stabilized aqueous formulation containing paracetamol
WO2009143558A1 (en) 2008-05-26 2009-12-03 Silphion Pty Limited Injectable formulations
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
JP2013006770A (ja) 2009-10-09 2013-01-10 Ssp Co Ltd アセトアミノフェン含有経口液剤
BR112012031928B1 (pt) * 2010-06-30 2021-08-31 Troikaa Pharmaceuticals Ltd Composições farmacêuticas as quais incluem paracetamol e processo para preparação do mesmo

Also Published As

Publication number Publication date
AU2013282753B2 (en) 2017-03-02
CN104487051B (zh) 2017-12-12
DOP2014000302A (es) 2015-03-15
NI201400147A (es) 2015-04-13
SMT201600248B (it) 2016-08-31
CN104487051A (zh) 2015-04-01
MA37811A1 (fr) 2016-10-31
CL2014003536A1 (es) 2015-05-08
MX369264B (es) 2019-11-04
ECSP15000500A (es) 2015-11-30
MA37811B1 (fr) 2017-07-31
PL2874602T3 (pl) 2016-10-31
ITMI20121154A1 (it) 2013-12-30
NZ703829A (en) 2016-06-24
CY1117691T1 (el) 2017-05-17
GEP201706689B (en) 2017-06-26
SG11201408479WA (en) 2015-01-29
AR091633A1 (es) 2015-02-18
RS54844B1 (sr) 2016-10-31
IL236423A0 (en) 2015-02-26
MD4537C1 (ro) 2018-07-31
AU2013282753A1 (en) 2015-02-05
US20160128955A1 (en) 2016-05-12
BR112014032818B1 (pt) 2022-06-14
AP2014008152A0 (en) 2014-12-31
SI2874602T1 (sl) 2016-09-30
IL236423A (en) 2017-07-31
PT2874602T (pt) 2016-07-13
CA2876801A1 (en) 2014-01-03
CU20140150A7 (es) 2015-10-27
US20150148379A1 (en) 2015-05-28
WO2014002042A1 (en) 2014-01-03
CO7240357A2 (es) 2015-04-17
PH12015500178B1 (en) 2021-08-04
KR20150027160A (ko) 2015-03-11
TN2014000526A1 (en) 2016-03-30
ZA201409478B (en) 2016-01-27
JP5876620B2 (ja) 2016-03-02
EP2874602B1 (en) 2016-03-30
JP2015522004A (ja) 2015-08-03
EP2874602A1 (en) 2015-05-27
MD4537B1 (ro) 2017-12-31
KR102118227B1 (ko) 2020-06-03
ME02431B (me) 2016-09-20
MY169251A (en) 2019-03-19
UA117101C2 (uk) 2018-06-25
MD20140138A2 (ro) 2015-06-30
CR20150036A (es) 2015-03-13
PE20150331A1 (es) 2015-03-07
ES2578012T3 (es) 2016-07-20
EA201500065A1 (ru) 2015-10-30
EA028909B1 (ru) 2018-01-31
BR112014032818A2 (pt) 2017-06-27
SG10201704482YA (en) 2017-07-28
MX2014015402A (es) 2015-06-17
DK2874602T3 (en) 2016-07-04
HRP20160706T1 (hr) 2016-08-12
CA2876801C (en) 2020-11-03
US11344517B2 (en) 2022-05-31
PH12015500178A1 (en) 2015-04-06

Similar Documents

Publication Publication Date Title
Vree et al. Clinical pharmacology and the use of articaine for local and regional anaesthesia
RU2095060C1 (ru) Композиция, обладающая аналгетической или противовоспалительной активностью, способ аналгезии или лечения аллергических заболеваний
CN113143852B (zh) 延长持续时间的局部麻醉制剂
BR112019011961A2 (pt) formulação tópica, método para prover tratamento não-sistêmico prolongado para dor em um indivíduo humano necessitando do mesmo, método para formar um depósito subcutâneo de detomidina ou um sal do mesmo em um indivíduo humano, formulação tópica e método para prover o tratamento para dor em um indivíduo humano necessitando do mesmo
Norris Jr Local anesthetics
AU2013282753B2 (en) Injectable supersaturated acetaminophen solution for spinal administration
JPH09500620A (ja) 極小の運動遮断で鎮痛効果を示す医薬の製造におけるロピバカインの使用
JP2020519593A (ja) 溶解度を増強させた薬物含有製剤
KR102162587B1 (ko) 경막 내 반복 투여를 위한 클로로프로카인계 제약 조성물
US20100190860A1 (en) Methods for selectively enhancing antinociceptive potency of local anesthetics
DE69631597T2 (de) Kombination aus einem beta rezeptorblocker und einem opioid
OA17190A (en) Injectable supersaturated acetaminophen solution for spinal administration.
Ebied et al. Does intrathecal midazolam improve hyperbaric bupivacaine–fentanyl anesthesia in elderly patients?
Jagan et al. Frontiers in Medical Case Reports
Gielen Tom B. Vree* PhD
WO2013067612A1 (pt) Composição farmacêutica para preparação de um medicamento para tratar dores neuropáticas, dores associadas às doenças degenerativas crónicas e em pós-operatórios dolorosos de animais